Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.

• Lacosamide is an antiepileptic drug (AED) approved for the adjunctive treatment of partial-onset seizures in adults. Completed phase II/III clinical trials of lacosamide provide a valuable opportunity to evaluate clinically relevant aspects of the resulting large patient pool.

Keyword

Acetamides

administration & dosage

pharmacokinetics

therapeutic use

Adult

Anticonvulsants

administration & dosage

pharmacokinetics

therapeutic use

Clinical Trials

Phase II as Topic

Clinical Trials

Phase III as Topic

Dose-Response Relationship

Drug

Double-Blind Method

Epilepsies

Partial

drug therapy

physiopathology

surgery

Female

Humans

Male

Models

Biological

Multicenter Studies as Topic

Randomized Controlled Trials as Topic

Time Factors

Treatment Outcome

Publication and Content Type

ref (subject category)

art (subject category)